1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
LEOCLAN Co. Ltd.

LEOCLAN Co. Ltd.

TTSE:7681
965.00
JPY
-15.00
(-1.53%)
5.42BMarket Cap
Nov 13Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3,266.66
7,756.91
6,754.4
3,792.76
4,490.65
5,060.63
4,527.61
3,360.56
3,636.73
- -
Basic EPS, GAAP
41.56
107.88
137.1
20.84
66.64
74.3
46.12
23.09
25.85
- -
Free Cash Flow per Basic Share
-157.6
279.97
496.86
-336.39
210.55
33.23
43.93
-0.66
-28.57
- -
Dividend per Share
3.37
5.92
13.33
12.29
14.96
13.33
16.65
16.63
16.64
- -
Book Value per Share
484.98
615.7
725.8
802.93
855.78
915.41
946.33
943.51
951.55
968.49
Tangible Book Value per Share
466.23
601.85
713.57
787.58
840.34
901.05
932.3
931.02
935.36
532.1
Basic Weighted Avg Shares
6
3
5
6
6
6
6
6
6
6
Sales/Revenue/Turnover
19,061
25,716
36,109
21,997
26,347
29,767
26,632
19,804
21,490
- -
Operating Margin (%)
0.04
2.51
3.3
0.93
2.19
2.19
1.65
0.9
1.34
- -
Depreciation Expense
109
116
121
92
95
96
104
99
90
- -
Net Income, GAAP
243
358
733
121
391
437
271
136
153
- -
Effective Tax Rate (%)
20.26
42.18
36.55
36.14
30.98
31.77
33.8
43.59
44.41
- -
Profit Margin (%)
1.27
1.39
2.03
0.55
1.48
1.47
1.02
0.69
0.71
- -
Working Capital
2,794
3,476
4,145
4,490
4,861
5,214
5,416
5,616
5,132
5,601
LT Debt
515
404
338
127
93
- -
- -
- -
- -
4,375
Total Equity
2,905
3,682
4,341
4,818
5,160
5,538
5,724
5,741
5,819
5,925
Return on Invested Capital (%)
- -
9.12
15.7
2.54
7.46
7.88
5.06
1.73
2.74
- -
Return on Capital (%)
- -
8.63
15.81
2.23
7.14
7.41
4.53
2.05
2.32
- -
Return on Common Equity (%)
- -
11.14
18.73
2.7
8.03
8.39
4.95
2.44
2.73
- -

Capital Structure

JPY

•

in mil. unless spec.
Dec'24
Mar'24
Mar'26
ST Debt
- -
- -
650
LT Borrowings
- -
- -
4,375
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
5,419
5,420
5,418

Working Capital

JPY

•

in mil. unless spec.
Dec'24
Mar'24
Mar'26
Total Current Assets
10,452
12,328
19,969
Cash, Cash Equivalents & STI
4,845
5,936
7,561
Accounts Receivable, Net
5,406
6,191
11,013
Inventories
37
27
1,089
Total Current Liabilities
5,005
6,732
14,368
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
650
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
3.89%
1.36%
Free Cash Flow
- -
785.21%
4,242.84%
Net Income, GAAP
- -
31.97%
12.29%
Sales/Revenue/Turnover
- -
1.02%
8.51%
Total Cash Common Dividend
- -
7.56%
0.36%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,414
6,803
- -
- -
19,804
2025
- -
- -
- -
- -
21,490
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13.67
23.82
- -
- -
23.09
2025
- -
- -
- -
- -
25.85
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
16.63
2025
- -
- -
- -
- -
16.64
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Koji Takeuchi
Full Time Employees
155
Sector
Distribution services
Industry
Medical distributors
Address
2-4-26 Senrioka Settsu OS Japan 566-0001
IPO Date
Oct 2, 2019
Website
leoclan.co.jp
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
LEOCLAN Co.,Ltd. engages primarily in medical total solutions, providing comprehensive support to hospitals and welfare facilities through the sale of medical equipment, medical systems, and medical information systems; remote image diagnosis services; and meal provision services via its subsidiary Gate Co.,Ltd. The company offers detailed products and services including medical devices such as diagnostic imaging equipment, surgical instruments, and patient monitoring systems; medical facility construction and interior works; ICT solutions for healthcare; post-installation maintenance and after-sales support; teleradiology services through its Kyoto Promed operations; and cook-chill system meal deliveries for elderly care and welfare facilities using centralized kitchen production and vacuum-packed refrigerated distribution. Headquartered in Settsu, Osaka, Japan, and founded in 2001, LEOCLAN operates nationwide across Japan, targeting new hospital constructions, renovations, relocations, clinics, nursing homes, and educational institutions with a focus on the wholesale medical sector. In recent developments, the company completed the acquisition of Fascia Holdings Co.,Ltd. and its subsidiaries in October 2025 for approximately 7.1 billion yen, securing over 67% ownership to expand its medical device sales and rental portfolio in the Tokai region and enhance overall group scale, with expected EBITDA contributions of 2.5 times prior-year levels for fiscal 2026 despite integration costs of 150 million yen. Earlier in 2025, LEOCLAN executed multiple capital and business alliances, alongside absorbing its wholly-owned subsidiary LEOCLAN Tokai Co.,Ltd. to streamline operations. These moves reflect an aggressive M&A strategy leveraging net cash reserves to bolster stability, synergize with core medical total solutions (94% of revenue), and drive growth amid large-scale hospital projects.